My predecessors--Congressman Dingell, Congressman Waxman--very much believed that generics will lower prices.

In 2012, Superstorm Sandy brought devastation to my district in New Jersey. We were the hardest hit, if you will, by Sandy of any district in the tristate area.

We need to find out why this takes so long, make sure that they focus on defining whether a chemical is safe or not safe.

I am proud of my former agency but it is overmatched and unable to reduce unreasonable risks.

The Trump EPA's attack on workers goes beyond its refusal to properly implement TSCA.

Explicit worker protections are so essential because workers bear the brunt of chemical exposures and harm.

But it is not a ban. It doesn't apply to any ongoing uses.

When the REMs program was put into place as part of the Food and Drug Administration Amendment Act of 2Congress contemplated and ultimately made it explicit that these safety protocols should not be use as a means to delay generic…

The bipartisan law has lowered the cost of important medications and devices. It has sped up how medical innovations come to fruition, and this is a win for consumers.

The proposals before us today will close loopholes that some drug companies are exploiting to game the system.

I find it immensely troubling that they agency witnesses were not considered by the Democrats.

One way to achieve this goal is to facilitate greater competition from generic and biosimilar manufacturers.